Comparative characterization of OncoPro™ and Wnt-Based media reveals distinct phenotypic and pharmacologic states in patient-derived tumor organoids
Sofie SeghersiD, Maxim Le CompteiD, Felicia Rodrigues Fortes, Jana BaroeniD, Jasper Ott, Geert RoeyeniD, Vera HartmaniD, Samir Kumar‐SinghiD, Lenny Coppens, Michiel de MaatiD, Niels KomeniD, Sylvie Van den BroeckiD, Jody W. ValkiD, Wiebren A.A. TjalmaiD, Jeroen M. HendriksiD, Paul E. Van SchiliD, Gilles Van HaesendonckiD, Sofía L. J. PeetersiD, Hans PreneniD, Christophe DebeniD
Abstract
BackgroundPatient-derived tumor organoids (PDTOs) are strongly influenced by culture medium. We compared OncoPro (OP) Tumoroid Culture medium with conventional Wnt/R-spondin/noggin (Wnt) medium. This recently developed OP medium offers a standardized, serum-free alternative to Wnt-based formulations. MethodsWe compared OP and Wnt media across 36 PDTO lines from various malignancies (colorectal, pancreatic, breast, lung, gastric, gastroesophageal junction, biliary head- and neck and uknown primary), assessing establishment success. Selected PDTO models were subjected to downstream characterization, including morphological assessment and bulk transcriptomic profiling with comparison to public single-cell RNA sequencing reference datasets (n=11), whole-exome sequencing (WES) (n=9), and pharmacological response profiling to a 33-drug panel (n=3). ResultsAdaptation from Wnt medium to OP succeeded in 83.3% (15/18), whereas de novo establishment favored Wnt (33.3% vs 11.1%). Key oncogenic driver alterations were retained across matched organoid cultures, supporting preservation of tumor-relevant genomic features. Transcriptomic profiling confirmed preserved tumor-identity across media, while revealing different epithelial state programs: Wnt upregulated proliferation/stemness-associated genes (e.g. LGR5) and OP enriched adhesion-associated genes and inflammatory/TGF-{beta} programs. In scRNA databases OP signatures preferentially mapped to malignant epithelial compartments in pancreatic cancer, whereas Wnt signatures were linked to non-malignant epithelium. Similarly, in colon cancer OP signature mapped predominantly to the malignant epithelial compartments. Drug (n=33) screening in pancreatic- and colorectal cancer PDTOs (n=3) demonstrated consistent medium-dependent shifts: Wnt-grown PDTOs were globally more sensitive in the screened subset, particularly to MAPK-axis inhibitors and apoptosis-sensitizers, while OP-grown PDTOs exhibited relative resistance. ConclusionsCulture medium composition is a key determinant of PDTO phenotype, transcriptome and drug sensitivity. Wnt medium was associated with drug-sensitive states, whereas OP medium was associated with adhesion- and inflammatory-related programs, relative resistance in the screened subset of 33 drugs and closer alignment with malignant epithelial programs in the analyzed pancreatic / colorectal cancer single-cell atlases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The impact of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids
J. C. Lumibao, S. R. Okhovat, … D. D. Engle·bioRxiv·Jan 26, 2023
- Wnt stimulation and inhibition in the development and phenotype of patient-derived gallbladder organoids
Ankita Dutta, Payel Guha, … Dwijit GuhaSarkar·Biology of the CellPeer-reviewed·Jul 1, 2026
- Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution
Johann Gout, Lukas Perkhofer, … Alexander Kleger·bioRxiv·Apr 24, 2025
- Resolving Drug Effects In Patient-Derived Cancer Cells Links Organoid Responses To Genome Alterations
J. Neugebauer, F. M. Zickgraf, … C. Conrad·bioRxiv·Apr 6, 2017
- Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids.
S. Le Blanc, N. Ishaque, … O. Strobel·bioRxiv·Aug 26, 2021
- An off-the-shelf multi-well scaffold-supported platform for tumour organoid-based tissues
N. T. Li, N. C. Wu, … A. P. McGuigan·bioRxiv·Aug 14, 2022